2023 Q3 Form 10-Q Financial Statement

#000141057823001775 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $12.99M $7.959M
YoY Change 78.88% 14.79%
Cost Of Revenue $4.880M $3.225M
YoY Change 74.57% 11.98%
Gross Profit $8.112M $4.735M
YoY Change 81.59% 16.72%
Gross Profit Margin 62.44% 59.49%
Selling, General & Admin $3.718M $2.396M
YoY Change 143.36% 41.4%
% of Gross Profit 45.83% 50.6%
Research & Development $741.6K $851.3K
YoY Change 15.47% 25.86%
% of Gross Profit 9.14% 17.98%
Depreciation & Amortization $437.9K $86.44K
YoY Change 384.77% -2.96%
% of Gross Profit 5.4% 1.83%
Operating Expenses $4.460M $3.247M
YoY Change 105.51% 36.97%
Operating Profit $3.653M $1.488M
YoY Change 58.99% -11.76%
Interest Expense -$307.6K $185.7K
YoY Change -712.97% 1679.96%
% of Operating Profit -8.42% 12.48%
Other Income/Expense, Net $19.81K $90.05K
YoY Change 25.14% 316.74%
Pretax Income $3.365M $1.763M
YoY Change 42.37% 2.64%
Income Tax $730.2K $340.0K
% Of Pretax Income 21.7% 19.28%
Net Earnings $2.635M $1.423M
YoY Change 64.46% 4.72%
Net Earnings / Revenue 20.28% 17.88%
Basic Earnings Per Share $0.08
Diluted Earnings Per Share $0.15 $0.08
COMMON SHARES
Basic Shares Outstanding 17.45M 17.44M
Diluted Shares Outstanding 17.58M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.097M $2.572M
YoY Change -82.05% -82.31%
Cash & Equivalents $3.097M $2.572M
Short-Term Investments
Other Short-Term Assets $449.8K $775.3K
YoY Change 23.19% 176.52%
Inventory $6.140M $5.743M
Prepaid Expenses
Receivables $9.744M $5.944M
Other Receivables $0.00 $0.00
Total Short-Term Assets $34.67M $25.94M
YoY Change 22.95% 4.64%
LONG-TERM ASSETS
Property, Plant & Equipment $7.892M $10.05M
YoY Change 25.43% 57.43%
Goodwill $3.558M $4.608M
YoY Change
Intangibles $16.19M $20.91M
YoY Change 26719.98% 33957.23%
Long-Term Investments
YoY Change
Other Assets $191.7K $198.3K
YoY Change 16.67% 17.43%
Total Long-Term Assets $28.28M $36.41M
YoY Change 334.93% 433.23%
TOTAL ASSETS
Total Short-Term Assets $34.67M $25.94M
Total Long-Term Assets $28.28M $36.41M
Total Assets $62.96M $62.35M
YoY Change 81.41% 97.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.337M $767.1K
YoY Change 88.66% 1.94%
Accrued Expenses $2.918M $5.275M
YoY Change -1.82% 213.35%
Deferred Revenue $143.4K $103.0K
YoY Change -44.69% -68.72%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.000M $2.000M
YoY Change
Total Short-Term Liabilities $6.399M $8.145M
YoY Change 62.4% 194.58%
LONG-TERM LIABILITIES
Long-Term Debt $17.50M $18.00M
YoY Change
Other Long-Term Liabilities $421.5K $420.9K
YoY Change 2697.93% 2186.9%
Total Long-Term Liabilities $17.92M $18.42M
YoY Change 118861.22% 99975.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.399M $8.145M
Total Long-Term Liabilities $17.92M $18.42M
Total Liabilities $24.32M $26.57M
YoY Change 514.87% 854.43%
SHAREHOLDERS EQUITY
Retained Earnings $5.669M $3.034M
YoY Change -1678.84% -254.72%
Common Stock $54.34M $54.12M
YoY Change 3.54% 3.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $38.64M $35.78M
YoY Change
Total Liabilities & Shareholders Equity $62.96M $62.35M
YoY Change 81.41% 97.21%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $2.635M $1.423M
YoY Change 64.46% 4.72%
Depreciation, Depletion And Amortization $437.9K $86.44K
YoY Change 384.77% -2.96%
Cash From Operating Activities $1.156M -$1.274M
YoY Change -454.73% -142.72%
INVESTING ACTIVITIES
Capital Expenditures $128.4K $84.93K
YoY Change -210.49%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$35.86M
YoY Change -100.0%
Cash From Investing Activities -$128.4K -$35.94M
YoY Change -104.67% 46660.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -501.1K 20.00M
YoY Change -276.46% 116518.08%
NET CHANGE
Cash From Operating Activities 1.156M -1.274M
Cash From Investing Activities -128.4K -35.94M
Cash From Financing Activities -501.1K 20.00M
Net Change In Cash 526.7K -17.22M
YoY Change -80.56% -689.08%
FREE CASH FLOW
Cash From Operating Activities $1.156M -$1.274M
Capital Expenditures $128.4K $84.93K
Free Cash Flow $1.028M -$1.359M
YoY Change -415.34% -144.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
dei Entity Central Index Key
EntityCentralIndexKey
0000836690
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
0
CY2022Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
0
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
0
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-31157
dei Entity Registrant Name
EntityRegistrantName
INNOVATIVE SOLUTIONS AND SUPPORT, INC.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-2507402
dei Entity Address Address Line1
EntityAddressAddressLine1
720 Pennsylvania Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Exton
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19341
dei City Area Code
CityAreaCode
610
dei Local Phone Number
LocalPhoneNumber
646-9800
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
ISSC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17446990
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2572233
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17250546
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5944015
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4297457
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
252162
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
162742
CY2023Q2 us-gaap Inventory Net
InventoryNet
5742613
CY2022Q3 us-gaap Inventory Net
InventoryNet
5349104
CY2023Q2 issc Prepaid Inventory
PrepaidInventory
10036160
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1390034
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1142470
CY2023Q2 us-gaap Assets Current
AssetsCurrent
25937217
CY2022Q3 us-gaap Assets Current
AssetsCurrent
28202319
CY2023Q2 us-gaap Goodwill
Goodwill
4608041
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20914885
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
60348
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10046444
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6292189
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
643708
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
46487
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
198333
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103980
CY2023Q2 us-gaap Assets
Assets
62348628
CY2022Q3 us-gaap Assets
Assets
34705323
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
767096
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
708845
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5275041
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2972275
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
102953
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
259183
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8145090
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3940303
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18000000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
420949
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15065
CY2023Q2 us-gaap Liabilities
Liabilities
26566039
CY2022Q3 us-gaap Liabilities
Liabilities
3955368
us-gaap Operating Expenses
OperatingExpenses
7288952
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1487636
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19535219
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19412664
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
19533
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
19413
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
54097502
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
52458121
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3034091
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-359042
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2096451
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2096451
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
21368537
CY2022Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
21368537
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
35782589
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
30749955
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62348628
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34705323
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7959208
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6935976
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21815917
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
20477574
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3224562
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2879462
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8617317
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8270729
CY2023Q2 us-gaap Gross Profit
GrossProfit
4734646
CY2022Q2 us-gaap Gross Profit
GrossProfit
4056514
us-gaap Gross Profit
GrossProfit
13198600
us-gaap Gross Profit
GrossProfit
12206845
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
851296
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
676381
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2387939
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2062937
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2395714
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1694233
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7104212
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5226015
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3247010
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2370614
us-gaap Operating Expenses
OperatingExpenses
9492151
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1685900
us-gaap Operating Income Loss
OperatingIncomeLoss
3706449
us-gaap Operating Income Loss
OperatingIncomeLoss
4917893
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
185652
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
10429
us-gaap Investment Income Interest
InvestmentIncomeInterest
432495
us-gaap Investment Income Interest
InvestmentIncomeInterest
10871
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
90049
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21608
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
131504
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
49401
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1763337
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1717937
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4270448
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4978165
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
339958
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
358763
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
877315
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1056363
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1423379
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1359174
us-gaap Net Income Loss
NetIncomeLoss
3393133
us-gaap Net Income Loss
NetIncomeLoss
3921802
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17576969
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17261349
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17415358
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17253822
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17577588
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17265798
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17419265
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17255305
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
34145126
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
214084
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1423379
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
35782589
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
27397889
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
58419
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17154
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1359174
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
28832636
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
30749955
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1230655
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
408846
us-gaap Net Income Loss
NetIncomeLoss
3393133
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
35782589
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
24585081
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
308599
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17154
us-gaap Net Income Loss
NetIncomeLoss
3921802
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
28832636
us-gaap Profit Loss
ProfitLoss
3393133
us-gaap Profit Loss
ProfitLoss
3921802
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
258892
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
278164
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
646172
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
135273
us-gaap Restricted Stock Expense
RestrictedStockExpense
584483
us-gaap Restricted Stock Expense
RestrictedStockExpense
173326
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
44400
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-357
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-597221
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
785737
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1646558
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1042975
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
89420
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
393509
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
264789
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
71679
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-69344
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
104626
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
58251
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
128859
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-854793
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
357566
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-133370
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-119855
issc Increase Decrease In Contract Liability
IncreaseDecreaseInContractLiability
-156230
issc Increase Decrease In Contract Liability
IncreaseDecreaseInContractLiability
-88388
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
937925
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6420371
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
165084
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
161230
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
35860000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36025084
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-161230
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
20000000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
408846
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17154
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20408846
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17154
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14678313
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6276295
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17250546
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8265606
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2572233
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14541901
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1608506
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
390481
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;"><span style="font-style:italic;font-weight:bold;">Reclassification</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company presented intangible assets, net separately in the consolidated balance sheet as of June 30, 2023. In order to conform to the presentation of the consolidated balance sheet as of June 30, 2023, the Company reclassified $60,348 from other assets to intangible assets, net in the consolidated balance sheet as of September 30, 2022. This reclassification has no impact on the Company’s net income for the three months ended June 30, 2023 and 2022 and the nine months ended June 30, 2023 and 2022.</p>
CY2022Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
60348
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 9pt 36pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 9pt 0pt;">The financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, which require management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Estimates are used in accounting for, among other items, valuation of tangible and intangible assets acquired, long term contracts, evaluation of allowances for doubtful accounts, product warranty cost liabilities, income taxes, engineering and material costs on Engineering Development Contract (“EDC”) programs, percentage of completion on EDC contracts, the useful lives of long-lived assets for depreciation and amortization, the recoverability of long-lived assets, evaluation of goodwill impairment, and contingencies. Estimates and assumptions are reviewed periodically and the effects of changes, if any, are reflected in the consolidated statements of operations in the period they are determined.</p>
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
162742
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
259183
us-gaap Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination
89420
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-240944
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
84714
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
252162
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
102953
issc Percentage Of Employees Who Were Engineers Engaged In Engineering Development Projects
PercentageOfEmployeesWhoWereEngineersEngagedInEngineeringDevelopmentProjects
0.23
issc Standard Product Warranty Accrual Length Of Warranty Period
StandardProductWarrantyAccrualLengthOfWarrantyPeriod
P24M
CY2023Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
53419
CY2022Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
51590
CY2023Q2 issc Excess Funded Premiums Over Estimated Claims
ExcessFundedPremiumsOverEstimatedClaims
432703
CY2022Q3 issc Excess Funded Premiums Over Estimated Claims
ExcessFundedPremiumsOverEstimatedClaims
424155
CY2023Q2 issc Number Of Banks
NumberOfBanks
2
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5115987
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4451045
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
570487
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
795723
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
56139
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
102336
CY2023Q2 us-gaap Inventory Net
InventoryNet
5742613
CY2022Q3 us-gaap Inventory Net
InventoryNet
5349104
CY2023Q2 us-gaap Prepaid Insurance
PrepaidInsurance
614700
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
777311
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
775334
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
365159
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1390034
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1142470
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
21596506
CY2023Q2 issc Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
44400
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
637221
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20914885
CY2022Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
696506
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
636158
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
60348
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1063
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1063
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1063
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22150195
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18226302
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12103751
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11934113
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10046444
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6292189
CY2023Q2 us-gaap Depreciation
Depreciation
86439
CY2022Q2 us-gaap Depreciation
Depreciation
89072
us-gaap Depreciation
Depreciation
257829
us-gaap Depreciation
Depreciation
269567
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18407
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28680
CY2023Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
179926
CY2022Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
75300
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
198333
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103980
CY2023Q2 issc Prepaid Software Licenses Noncurrent
PrepaidSoftwareLicensesNoncurrent
56855
CY2022Q3 issc Prepaid Software Licenses Noncurrent
PrepaidSoftwareLicensesNoncurrent
0
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
589048
CY2022Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
607001
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
746576
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1030628
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
119129
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
364794
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13125
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13615
CY2023Q2 issc Accrued Supplier Purchase Orders Current
AccruedSupplierPurchaseOrdersCurrent
3531201
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
275962
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
956237
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5275041
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2972275
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
587650
CY2022Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
607001
CY2023Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
29119
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
63495
CY2023Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
27721
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
81448
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
589048
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
589048
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.193
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.205
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.209
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.212
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1423379
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1359174
us-gaap Net Income Loss
NetIncomeLoss
3393133
us-gaap Net Income Loss
NetIncomeLoss
3921802
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17576969
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17261349
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17415358
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17253822
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
619
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4449
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3907
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1483
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17577588
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17265798
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17419265
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17255305
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
128815
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
100000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
76636
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
312210
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
196577
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
66667
CY2023Q2 issc Equity Method Investments Ownership Percentage
EquityMethodInvestmentsOwnershipPercentage
0.10
issc Schedule Of Operating Lease Related Assets And Liabilities
ScheduleOfOperatingLeaseRelatedAssetsAndLiabilities
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:48.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:35.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td colspan="6" style="vertical-align:bottom;width:100%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Classification on the Consolidated Balance Sheet on June 30, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:48.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:48.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_tMOgk65Au0OEMeeZ4ypXaw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other assets</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,407</p></td></tr><tr><td style="vertical-align:bottom;width:48.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating leases- current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_yXPpNpG5D0it8IUpIHq4vQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Accrued expenses</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,125</p></td></tr><tr><td style="vertical-align:bottom;width:48.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating leases – noncurrent</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_qq-IbSYUjUyKQT-b4xmboA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other liabilities</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,282</p></td></tr><tr><td style="vertical-align:bottom;width:48.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,407</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p>
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18407
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13125
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5282
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
18407
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
3669
us-gaap Operating Lease Expense
OperatingLeaseExpense
11007
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y4M24D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
14676
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
6115
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20791
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2384
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
18407
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13125
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5282

Files In Submission

Name View Source Status
0001410578-23-001775-index-headers.html Edgar Link pending
0001410578-23-001775-index.html Edgar Link pending
0001410578-23-001775.txt Edgar Link pending
0001410578-23-001775-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
issc-20230630.xsd Edgar Link pending
issc-20230630x10q.htm Edgar Link pending
issc-20230630xex31d1.htm Edgar Link pending
issc-20230630xex31d2.htm Edgar Link pending
issc-20230630xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
issc-20230630_cal.xml Edgar Link unprocessable
issc-20230630_def.xml Edgar Link unprocessable
issc-20230630_lab.xml Edgar Link unprocessable
issc-20230630_pre.xml Edgar Link unprocessable
issc-20230630x10q_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending